Inventory Reduction And Market Recovery Will Secure Future Success

Published
21 Sep 24
Updated
15 May 25
AnalystConsensusTarget's Fair Value
US$20.30
4.1% undervalued intrinsic discount
15 May
US$19.46
Loading
1Y
36.8%
7D
2.5%

Author's Valuation

US$20.3

4.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 1.12%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 1.86%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Increased 2.20%

AnalystConsensusTarget has increased revenue growth from -2.5% to -3.6%.

Shared on19 Mar 25
Fair value Increased 2.09%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on11 Mar 25
Fair value Decreased 2.67%

AnalystConsensusTarget has increased revenue growth from -3.6% to -2.5% and increased shares outstanding growth rate from 0.0% to 0.0%.